Details of the Drug

General Information of Drug (ID: DMTEQEQ)

Drug Name
Galinpepimut-S
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 3 [1]
Chronic myeloid leukaemia 2A20 Phase 2 [2]
Malignant pleural mesothelioma 2C26.0 Phase 2 [3]
Mesothelioma 2C51.2 Phase 2 [2]
Multiple myeloma 2A83 Phase 2 [3]
Ovarian cancer 2C73 Phase 2 [2]
Chronic myelogenous leukaemia 2A20.0 Phase 1/2 [3]
⏷ Show the Full List of Indication(s)
Cross-matching ID
UNII
12R66419FZ
DrugBank ID
DB17271
TTD ID
D0M9OO
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT04229979) GPS Compared With BAT in AML CR2/CR2p. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)